Home
|
Learning Center
|
中文版
Publications
站内成果搜索:
搜索
Ataxic gait due to Giant Cystic Virchow-Robin Spaces: Case Report
Ataxin-2 interacts with the DEAD/H-box RNA helicase DDX6 and interferes with P-bodies and stress granules
Ataxia telangiectasia mutated is essential during adult neurogenesis
Ataxic form of autosomal recessive PEX10-related peroxisome biogenesis disorders with a novel compound heterozygous gene mutation and characteristic clinical phenotype
Ataxia with Oculomotor Apraxia Type 1 without Oculomotor Apraxia: A Case Report (vol 12, pg 126, 2016)
Ataxin-1 regulates epithelial-mesenchymal transition of cervical cancer cells
Ataxia-telangiectasia mutated interactor regulates head and neck cancer metastasis via KRas expression
Ataxia telangiectasia: presentation and diagnostic delay
Ataxia-telangiectasia (A-T): An emerging dimension of premature ageing
Ataxia With Oculomotor Apraxia Is Associated With the DNA Damage Repair Pathway
Ataxia in children: early recognition and clinical evaluation
Ataxin-3 consolidates the MDC1-dependent DNA double-strand break response by counteracting the SUMO-targeted ubiquitin ligase RNF4
Ataxin 2-binding protein 1 is a context- specific positive regulator of Notch signaling during neurogenesis in Drosophila melanogaster
Ataxia with oculomotor apraxia type 2: not always an easy diagnosis
Ataxia meets chorioretinal dystrophy and hypogonadism: Boucher-Neuhauser syndrome due to PNPLA6 mutations
Ataxin-1 oligomers induce local spread of pathology and decreasing them by passive immunization slows Spinocerebellar ataxia type 1 phenotypes
Ataxia-telangiectasia: Immunodeficiency and survival
Ataxin-2: From RNA Control to Human Health and Disease
Ataxia-telangiectasia like: A teenager carrying a new variant of the gen MRE11A
Ataxia and Headache in a Child A Case of Acute Cerebellar Infarction
Ataxias and hereditary spastic paraplegias
Ataxin-1 is involved in tumorigenesis of cervical cancer cells via the EGFR-RAS-MAPK signaling pathway
Ataxia telangiectasia and rad3 related (ATR)-promyelocytic leukemia protein (PML) pahway of the DNA damage response in the brain of rats administered arsenic trioxide
Ataxia telangiectasia in Turkey: multisystem involvement of 91 patients
Ataxia-Telangiectasia Mutated (ATM) Protein Signaling Participates in Development of Pulmonary Arterial Hypertension in Rats
Ataxia and Weakness in a Young Woman
Ataxia is Still an Important Clinical Finding in Severe High Altitude Illness
Ataxic Hemiparesis: Neurophysiological Analysis by Cerebellar Transcranial Magnetic Stimulation
Ataxin-3 Deubiquitination Is Coupled to Parkin Ubiquitination via E2 Ubiquitin-conjugating Enzyme
Ataxia-Telangiectasia Presenting With a Novel Immunodeficiency
Ataxia telangiectasia: a "disease model" to understand the cerebellar control of vestibular reflexes
Ataxia telangiectasia mutated (Atm) and DNA-PKcs kinases have overlapping activities during chromosomal signal joint formation
Ataxic Guillain-Barre syndrome and acute sensory ataxic neuropathy form a continuous spectrum
Ataxin-3 and its E3 partners: implications for Machado-Joseph disease
Ataxia and vertigo due to anomalous origin of the left vertebral artery
Ataxia telangiectasia syndrome: moonlighting ATM
Ataxia telangiectasia associated with nodular regenerative hyperplasia
Ataxia telangiectasia presenting as hyper IgM syndrome without neurologic signs
Ataxia rating scales are problematic in young children
Ataxia and the Cerebellum
Ataxia Telangiectasia and Rad3-Related Overexpressing Cancer Cells Induce Prolonged G(2) Arrest and Develop Resistance to Ionizing Radiation
Ataxia Rating Scales-Psychometric Profiles, Natural History and Their Application in Clinical Trials
Ataxin-2-Like Is a Regulator of Stress Granules and Processing Bodies
Ataxic hemiparesis in a patient with posterior cortical borderzone infarction
Ataxic sensory neuronopathy in a patient with systemic lupus erythematosus
Ataxia telangiectasia, Menkes kinky hair disease and neurocutaneous melanosis
Ataxia telangiectasia: a review
Ataxia-Telangiectasia Mutated Kinase: A Potential New Target for Suppressing Inflammation in Heart Failure?
Ataxia-Telangiectasia Mutated Kinase in the Control of Oxidative Stress, Mitochondria, and Autophagy in Cancer: A Maestro with a Large Orchestra
Ataxia-Telangiectasia-Mutated Protein Expression as a Prognostic Marker in Adenoid Cystic Carcinoma of the Salivary Glands
Ataxia Telangiectasia and Cancer Predisposition: Challenges in Management
Ataxin-3 promotes testicular cancer cell proliferation by inhibiting anti-oncogene PTEN
Ataxia-Telangiectasia Mutated (ATM) Kinase Regulates eNOS Expression and Modulates Radiosensitivity in Endothelial Cells Exposed to Ionizing Radiation
Ataxia telangiectasia mutated kinase deficiency impairs the autophagic response early during myocardial infarction
Ataxia-telangiectasia gene (ATM) mutation heterozygosity in breast cancer: a narrative review
Ataxin-3, the MJD1 gene product, interacts with the two human homologs of yeast DNA repair protein RAD23, HHR23A and HHR23B
阿塔峡鸡与湖北地方鸡遗传关系的微卫星标记分析
Ataxia telangiectasia mutated deficiency does not result in genetic susceptibility to 50 Hz magnetic fields exposure in mouse embryonic fibroblasts.
Ataxia Telangiectasia-Mutated (ATM)Polymorphisms and Risk of Lung Cancer in a Chinese Population
Ataxia with novel compound heterozygous PEX10 mutations and a literature review of PEX10-related peroxisome biogenesis disorders
Atayal's identification of sustainability: traditional ecological knowledge and indigenous science of a hunting culture
Atazanavir/ritonavir-based combination antiretroviral therapy for treatment of HIV-1 infection in adults
Atazanavir is not associated with an increased risk of cardio or cerebrovascular disease events
Atazanavir and chest pain
Atazanavir-Based Therapy Is Associated with Higher Hepatitis C Viral Load in HIV Type 1-Infected Subjects with Untreated Hepatitis C
Atazanavir and Other Determinants of Hyperbilirubinemia in a Cohort of 1150 HIV-Positive Patients: Results from 9 Years of Follow-Up
Atazanavir and lopinavir profile in pregnant women with HIV: tolerability, activity and pregnancy outcomes in an observational national study
Atazanavir exposure is effective during pregnancy regardless of tenofovir use
Atazanavir-Induced Urine Crystals Demonstrated by Infrared Spectroscopic Analysis
Atazanavir-Associated Choledocholithiasis Leading to Acute Hepatitis in an HIV-Infected Adult
Atazanavir exposure in utero and neurodevelopment in infants: a comparative safety study
Atazanavir dose reduction: one size does not fit all
Atazanavir/ritonavir monotherapy: 96 week efficacy, safety and bone mineral density from the MODAt randomized trial
Atazanavir Concentration in Hair Is the Strongest Predictor of Outcomes on Antiretroviral Therapy
Atazanavir pharmacokinetics, efficacy and safety in pregnancy: a systematic review
Atazanavir Plus Ritonavir or Efavirenz as Part of a 3-Drug Regimen for Initial Treatment of HIV-1
Atazanavir Plus Ritonavir or Efavirenz as Part of a 3-Drug Regimen for Initial Treatment of HIV-1 RESPONSE
Atazanavir: its role in HIV treatment
Atazanavir A Review of its Use in the Management of HIV-1 Infection
Atazanavir intracellular concentrations remain stable during pregnancy in HIV-infected patients
Atazanavir-Associated Crystalline Nephropathy
Atazanavir Pharmacokinetics With and Without Tenofovir During Pregnancy
Atazanavir and atazanavir/ritonavir pharmacokinetics in HIV-infected infants, children, and adolescents